November 03, 2026
Cancer drug developer Karyopharm Therapeutics Inc. on Tuesday secured a Texas bankruptcy judge's approval to borrow $25 million in Chapter 11 financing and solicit bids for its business, as the company looks to merge with biotechnology firm Ayrmid and trim debt through a prepackaged bankruptcy plan.
November 03, 2026
An Outback Steakhouse franchisee, a pharmaceutical cancer treatment company and a boutique fitness studio operator were among the debtors entering bankruptcy in the last week.
November 02, 2026
Pharmaceutical company Karyopharm Therapeutics Inc. on Monday filed for Chapter 11 protection in a Texas bankruptcy court with $441.5 million in debt and a plan to merge with biotechnology firm Ayrmid Ltd.